首页 | 本学科首页   官方微博 | 高级检索  
     


Treatment of ocular rosacea
Authors:Edward J. Wladis  Alejandro P. Adam
Affiliation:1. Department of Ophthalmology, Ophthalmic Plastic Surgery, Lions Eye Institute, Albany Medical College, Slingerlands, New York, USA;2. Division of Otolaryngology, Department of Surgery, Albany Medical College, Slingerlands, New York, USA;3. Department of Molecular and Cellular Physiology, Albany Medical College, Slingerlands, New York, USA;4. Department of Ophthalmology, Lions Eye Institute, Albany Medical College, Slingerlands, New York, USA
Abstract:Although rosacea is a common entity with significant cosmetic, socioeconomic, and vision-threatening impacts, this disorder remains incurable. Furthermore, until quite recently many of the therapeutic options for rosacea had not been assessed through rigorous clinical testing with meaningful outcome measures. Nonetheless, new medical and surgical interventions that have been validated in well-designed trials hold the promise of treating rosacea more effectively. Furthermore, recent enhancements in our understanding of the cellular and molecular biology offer highly translational insights that will hopefully lead to the development of new treatment options for rosacea. We review the evidence for these therapies and discuss new scientific findings that can be exploited for new therapeutic interventions.
Keywords:rosacea  ocular surface disease  meibomian gland disease  dry eye  eyelid
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号